Biosyent Inc. has seen some fluctuations in its stock price this week, reflecting a modest performance amid recent strategic moves.
Biosyent Inc. (RX.V) experienced a slight decline of 0.75% in its stock price today, closing at C$15.69. Over the week, the stock dipped only 0.13%, but it has risen by 5.67% over the past month. Year-to-date, Biosyent's stock has increased by 24.22%, indicating a generally positive trend for investors.
Advertisement
Biosyent Inc.
RX.V
RX.V
Biosyent Inc.
WealthAwesomeMarket cap
$189.83M
P/E
19.9x
Div. yield
1.25%
Div. / share
$0.21
52W high
$17.50
52W low
$10.49
1W change
+2.52%
Beta
0.59
Analyst Price Targets
Based on analyst covering RX · as of Sep 17, 2026
Wall Street analysts forecast RX stock price to rise 6.4% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.00
+6.4% Upside
Current Price
C$16.91
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RX's historical volatility
30-Day Vol
35.9%
Annualized
90-Day Vol
29.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$20.22
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$17.95 | C$15.86 – C$20.32 |
| 60 trading days | C$19.05 | C$15.99 – C$22.70 |
| 90 trading days | C$20.22 | C$16.31 – C$25.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on the company's upcoming earnings release and recent acquisition activity, as these developments could influence future performance and market sentiment.
C$15.69 closing price reflects a 0.75% decline today.
With a market cap of C$180.6 million and a profit margin of 17.7%, Biosyent continues to show solid fundamentals in the health care sector.
Bull case
Biosyent's recent acquisition of Oral Science Inc. is expected to enhance its product offerings and market reach, which could drive future growth.
Bear case
The recent price movement, coupled with lower trading volume compared to the 20-day average, may raise concerns about investor confidence and market interest.
Price Action Overview
Advertisement
Biosyent Inc. (RX.V) closed at C$15.69 today, down 0.75% from the previous session. Over the past week, the stock has shown a slight decline of 0.13%. However, in the last month, it has gained 5.67%, showing some resilience despite market fluctuations. Year-to-date, Biosyent has performed well, with a notable increase of 24.22%, indicating a generally favorable outlook among investors.
Recent Company News
No major news has been reported this week for Biosyent Inc. However, the company recently completed the acquisition of Oral Science Inc., a Canadian distributor of dental hygiene and oral health products, for $25.5 million. This strategic move is expected to strengthen Biosyent's presence in the oral health sector and could enhance its revenue streams moving forward.
Technical Picture
Biosyent's stock is currently trading above its 50-day moving average of C$14.94 by about 5.0%, and it is also above its 200-day moving average of C$14.12 by approximately 11.2%. The stock's 52-week range is between C$10.49 and C$16.25, indicating it has traded within 90% of this range recently. With a beta of 0.64, the stock is less volatile compared to the broader market. The latest trading volume of 5,326 shares is notably lower than the 20-day average of 9,570 shares, suggesting a decrease in trading activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
